Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramit Magen-Rimon

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Obesity Facts|July 26, 2021
Bariatric Surgery-Associated MyelopathySewar Asakly, Ramit Magen-Rimon, Ahmad Ighbariya, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 16, 2026
Safety and efficacy of weekly adalimumab 80 mg therapy in pediatric Crohn's diseaseEyal Cohen-Sela, Anat Yerushalmy-Feler, Firas Rinawi, et al.
Alimentary Pharmacology & Therapeutics|March 9, 2023
5-aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease-A nationwide cohort studyOhad Atia, Idan Goren, Tali Sharar Fischler, et al.
Inflammatory Bowel Diseases|January 8, 2024
Durability of Adalimumab and Infliximab in Children With Crohn's Disease: A Nationwide Comparison From the epi-IIRN CohortOhad Atia, Chagit Friss, Gili Focht, et al.
Inflammatory Bowel Diseases|April 21, 2023
Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRNOhad Atia, Ramit Magen Rimon, Natan Ledderman, et al.
Journal of Crohn'S & Colitis|July 19, 2023
Durability of the First Biologic in Patients with Crohn's Disease: A Nationwide Study from the epi-IIRNOhad Atia, Chagit Friss, Gili Focht, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 27, 2024
Juvenile polyposis syndrome in children: The impact of SMAD4 and BMPR1A mutations on clinical phenotype and polyp burdenShlomi Cohen, Anat Yerushalmy-Feler, Isabel Rojas, et al.
Inflammatory Bowel Diseases|April 5, 2024
Durability of the First Biologic in Children and Adults With Ulcerative Colitis: A Nationwide Study from the epi-IIRNOhad Atia, Chagit Friss, Gili Focht, et al.
Digestive Diseases and Sciences|December 26, 2024
Characteristics and Outcomes of Over a Million Patients with Inflammatory Bowel Disease in Seven Countries: Multinational Cohort Study and Open Data ResourceChen Yanover, Ramit Magen-Rimon, Erica A Voss, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 9, 2022
Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed-up Study): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHANAnat Yerushalmy-Feler, Gemma Pujol-Muncunill, Javier Martin-de-Carpi, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Obesity Facts|July 26, 2021
Bariatric Surgery-Associated MyelopathySewar Asakly, Ramit Magen-Rimon, Ahmad Ighbariya, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 16, 2026
Safety and efficacy of weekly adalimumab 80 mg therapy in pediatric Crohn's diseaseEyal Cohen-Sela, Anat Yerushalmy-Feler, Firas Rinawi, et al.
Alimentary Pharmacology & Therapeutics|March 9, 2023
5-aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease-A nationwide cohort studyOhad Atia, Idan Goren, Tali Sharar Fischler, et al.
Inflammatory Bowel Diseases|January 8, 2024
Durability of Adalimumab and Infliximab in Children With Crohn's Disease: A Nationwide Comparison From the epi-IIRN CohortOhad Atia, Chagit Friss, Gili Focht, et al.
Inflammatory Bowel Diseases|April 21, 2023
Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRNOhad Atia, Ramit Magen Rimon, Natan Ledderman, et al.
Journal of Crohn'S & Colitis|July 19, 2023
Durability of the First Biologic in Patients with Crohn's Disease: A Nationwide Study from the epi-IIRNOhad Atia, Chagit Friss, Gili Focht, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 27, 2024
Juvenile polyposis syndrome in children: The impact of SMAD4 and BMPR1A mutations on clinical phenotype and polyp burdenShlomi Cohen, Anat Yerushalmy-Feler, Isabel Rojas, et al.
Inflammatory Bowel Diseases|April 5, 2024
Durability of the First Biologic in Children and Adults With Ulcerative Colitis: A Nationwide Study from the epi-IIRNOhad Atia, Chagit Friss, Gili Focht, et al.
Digestive Diseases and Sciences|December 26, 2024
Characteristics and Outcomes of Over a Million Patients with Inflammatory Bowel Disease in Seven Countries: Multinational Cohort Study and Open Data ResourceChen Yanover, Ramit Magen-Rimon, Erica A Voss, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 9, 2022
Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed-up Study): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHANAnat Yerushalmy-Feler, Gemma Pujol-Muncunill, Javier Martin-de-Carpi, et al.
Pageof 3